Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention

Future Cardiol. 2011 May;7(3):281-5. doi: 10.2217/fca.11.20.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary / methods*
  • Angioplasty, Balloon, Coronary / trends
  • Anticoagulants / therapeutic use
  • Coronary Artery Disease / therapy*
  • Cyclic N-Oxides / therapeutic use
  • Factor IXa / antagonists & inhibitors*
  • Fondaparinux
  • Heparin / therapeutic use
  • Hirudins
  • Humans
  • Peptide Fragments / therapeutic use
  • Polysaccharides / therapeutic use
  • Pyridines / therapeutic use
  • Recombinant Proteins / therapeutic use

Substances

  • Anticoagulants
  • Cyclic N-Oxides
  • Hirudins
  • Peptide Fragments
  • Polysaccharides
  • Pyridines
  • Recombinant Proteins
  • Heparin
  • Factor IXa
  • Fondaparinux
  • otamixaban
  • bivalirudin